newstodate.aero
Sep 22, 2020 (newstodate): SAS Cargo has successfully completed the re-certification under IATA's CEIV Pharma program.
And at the same time, SAS Cargo became one of the first in the industry to perform a full audit of all its pharma processes remotely under the current Covid-19 restrictions.
SAS Cargo obtained the CEIV Pharma certificate on July 31, 2017, joining the growing rank of carriers wooing the pharma industries with integrated air logistic solutions.
SAS Cargo also launched its SAS Pharma Cargo product with a focus on ensuring the integrity of temperature-sensitive pharmaceutical and healthcare products in air transportation on its route network.
In addition to using the latest equipment, processes and operating procedures, the SAS Cargo Pharma product is also using active GPS trackers to monitor the shipment to assure accurate temperature along the entire transport chain.
One recent result from SAS Cargo's CEIV Pharma certification is the non-exclusive contract signed in August 2020 and running till end of 2022 with the Danish pharma giant Novo Nordisk, securing the company with capacity to transport medical shipments on vital lanes to the USA, Japan and China.
And at the same time, SAS Cargo became one of the first in the industry to perform a full audit of all its pharma processes remotely under the current Covid-19 restrictions.
SAS Cargo obtained the CEIV Pharma certificate on July 31, 2017, joining the growing rank of carriers wooing the pharma industries with integrated air logistic solutions.
SAS Cargo also launched its SAS Pharma Cargo product with a focus on ensuring the integrity of temperature-sensitive pharmaceutical and healthcare products in air transportation on its route network.
In addition to using the latest equipment, processes and operating procedures, the SAS Cargo Pharma product is also using active GPS trackers to monitor the shipment to assure accurate temperature along the entire transport chain.
One recent result from SAS Cargo's CEIV Pharma certification is the non-exclusive contract signed in August 2020 and running till end of 2022 with the Danish pharma giant Novo Nordisk, securing the company with capacity to transport medical shipments on vital lanes to the USA, Japan and China.